Firmenbeschreibung
Gilead Sciences Inc. ist ein unabhängiges und weltweit operierendes Biotechnologie-Unternehmen. Kernkompetenz ist die Entwicklung von therapeutischen Lösungen für die Behandlung von lebensbedrohlichen Infektionskrankheiten. Dabei konzentriert sich Gilead Sciences insbesondere auf systemische Pilzinfektionen, Tumorerkrankungen, HIV und Hepatitis-B. Die Arzneimittel enthalten hauptsächlich Wirkstoffe, die im eigenen Haus entwickelt wurden. Mit der Übernahme der Biotechfirma Pharmasset hat sich Gilead verschiedene aussichtsreiche Medikamente für die Behandlung von Leberentzündungen (Hepatitis C) gesichert.
KeyData
| endOfFinancialYear: | 31.12.2024 00:00 |
| stockholderStructure: | BlackRock Inc. (9.85614%),Vanguard Group (8.97557%),Capital World Investors (6.69133%),CAPITAL RESEARCH GLOBAL INVESTOR (4.78846%),State Street Corporation (4.77877%),Dodge & Cox (2.67247%),GEODE CAPITAL MANAGEMENT LLC (2.02866%),Wellington Management Group (1.49537%),Morgan Stanley (1.42888%),FMR LLC. (1.37236%) |
| sharesOutstanding: | 1246000000.0000 |
| ceo: | Daniel O’Day |
| board: | Andrew Dickinson, Jyoti Mehra, Stacey Ma, Flavius Martin, Johanna Mercier, Cindy Perettie, Deborah H. Telman, Merdad Parsey |
| supervisoryBoard: | Daniel O’Day, Jacqueline K. Barton, Jeffrey A. Bluestone, Sandra J. Horning, Kelly A. Kramer, Harish Manwani, Anthony Welters, Ted W. Love, Javier J. Rodriguez |
| countryID: | 20 |
| freeFloat: | 99.8900 |
| faceValue: | 0.0010 |
| faceValueCurrencyID: | 4 |
| faceValueCurrency: | USD |
| sectorName: | Pharmazeutische Industrie |
| industryName: | Gesundheitswesen |
| subsectorName: | Pharmazeutische Industrie |
| country: | USA |
| countryName: | USA |
Kontakt
| name: | Jacquie Ross |
| phone: | +1-650-524-7792 |
| email: | investor_relations@gilead.com |
| irWebSite: | https://investors.gilead.com/ |
Adresse
| street: | 333 Lakeside Drive |
| city: | Foster City, California 94404, USA |
| phone: | +1-650-574-3000 |
| fax: | +1-650-578-9264 |
| webSite: | www.gilead.com |
| email: | corporate_development@gilead.com |
Finanzen (kurz)
| year: | 2021 | cash: | 5338.0000 |
| balanceSheetTotal: | 67952.0000 | liabilities: | 46888.0000 |
| shareCapital: | 1.0000 | totalShareholdersEquity: | 21064.0000 |
| sales: | 27305.0000 | investment: | 0.0000 |
| incomeBeforeTaxes: | 8278.0000 | netIncome: | 6225.0000 |
| cashFlow: | -659.0000 | employees: | 14000 |
| currencyID: | 4 | units: | 1000000 |
| currency: | USD |
| year: | 2022 | cash: | 5412.0000 |
| balanceSheetTotal: | 63171.0000 | liabilities: | 41962.0000 |
| shareCapital: | 1.0000 | totalShareholdersEquity: | 21209.0000 |
| sales: | 27281.0000 | incomeBeforeTaxes: | 5814.0000 |
| netIncome: | 4592.0000 | cashFlow: | 74.0000 |
| currencyID: | 4 | units: | 1000000 |
| currency: | USD |
| year: | 2023 | cash: | 6085.0000 |
| balanceSheetTotal: | 62125.0000 | liabilities: | 39376.0000 |
| shareCapital: | 1.0000 | totalShareholdersEquity: | 22749.0000 |
| sales: | 27116.0000 | incomeBeforeTaxes: | 6859.0000 |
| netIncome: | 5665.0000 | cashFlow: | 673.0000 |
| currencyID: | 4 | units: | 1000000 |
| currency: | USD |
Finanzen (kurz)
| year: | 2021 |
| cash: | 5338.0000 |
| balanceSheetTotal: | 67952.0000 |
| liabilities: | 46888.0000 |
| shareCapital: | 1.0000 |
| totalShareholdersEquity: | 21064.0000 |
| sales: | 27305.0000 |
| investment: | 0.0000 |
| incomeBeforeTaxes: | 8278.0000 |
| netIncome: | 6225.0000 |
| cashFlow: | -659.0000 |
| employees: | 14000 |
| currencyID: | 4 |
| units: | 1000000 |
| currency: | USD |
| year: | 2022 |
| cash: | 5412.0000 |
| balanceSheetTotal: | 63171.0000 |
| liabilities: | 41962.0000 |
| shareCapital: | 1.0000 |
| totalShareholdersEquity: | 21209.0000 |
| sales: | 27281.0000 |
| incomeBeforeTaxes: | 5814.0000 |
| netIncome: | 4592.0000 |
| cashFlow: | 74.0000 |
| currencyID: | 4 |
| units: | 1000000 |
| currency: | USD |
| year: | 2023 |
| cash: | 6085.0000 |
| balanceSheetTotal: | 62125.0000 |
| liabilities: | 39376.0000 |
| shareCapital: | 1.0000 |
| totalShareholdersEquity: | 22749.0000 |
| sales: | 27116.0000 |
| incomeBeforeTaxes: | 6859.0000 |
| netIncome: | 5665.0000 |
| cashFlow: | 673.0000 |
| currencyID: | 4 |
| units: | 1000000 |
| currency: | USD |
Finanzen (ausführlich)
| year: | 2022 | units: | 1000000 |
| balanceSheetTotal: | 63171.0000 | cash: | 5412.0000 |
| currentAssets: | 14443.0000 | fixedAssets: | 48728.0000 |
| liabilities: | 11237.0000 | totalLiabilitiesEquity: | 63171.0000 |
| totalShareholdersEquity: | 21209.0000 | property: | 5475.0000 |
| intangibleAssets: | 28894.0000 | longTermInvestments: | 1245.0000 |
| inventories: | 1507.0000 | accountsReceivable: | 4777.0000 |
| accountsPayable: | 905.0000 | liabilitiesTotal: | 41962.0000 |
| longTermDebt: | 22957.0000 | shortTermDebt: | 2273.0000 |
| minorityInterests: | -31.0000 | commonStock: | 1.0000 |
| preferredStock: | 0.0000 | sales: | 27281.0000 |
| netIncome: | 4592.0000 | operatingResult: | 7330.0000 |
| incomeInterest: | -935.0000 | investments: | 4977.0000 |
| incomeTaxes: | -1248.0000 | costGoodsSold: | 5657.0000 |
| grossProfit: | 21624.0000 | minorityInterestsProfit: | 26.0000 |
| cashFlow: | 9072.0000 | cashFlowInvesting: | -2466.0000 |
| cashFlowFinancing: | -6469.0000 | cashFlowTotal: | 74.0000 |
| accountingStandard: | US GAAP | equityRatio: | 33.5740 |
| debtEquityRatio: | 1.1896 | liquidityI: | 0.4816 |
| liquidityII: | 0.9067 | netMargin: | 16.8322 |
| grossMargin: | 79.2640 | cashFlowMargin: | 33.2539 |
| ebitMargin: | 26.8685 | ebitdaMargin: | 0.0000 |
| preTaxROE: | 27.4129 | preTaxROA: | 9.2036 |
| roe: | 21.6512 | roa: | 7.2692 |
| netIncomeGrowth: | -26.2329 | revenuesGrowth: | -0.0879 |
| taxExpenseRate: | -21.4654 | equityTurnover: | 1.2863 |
| epsBasic: | 3.6600 | epsDiluted: | 3.6400 |
| epsBasicGrowth: | -26.2097 | shareCapital: | 1.0000 |
| incomeBeforeTaxes: | 5814.0000 | priceEarningsRatioCompany: | 23.4563 |
| priceCashFlowRatio: | 11.8016 | dividendYield: | 3.4013 |
| bookValuePerShare: | 17.0066 | marketCap: | 107063977470.9000 |
| earningsYield: | 4.2632 | pegRatio: | -0.8949 |
| cashFlowPerShare: | 7.2744 | netAssetsPerShare: | 16.9817 |
| priceBookValueRatio: | 5.0480 | dividendsPerShare: | 2.9200 |
| priceEarningsRatio: | 23.3153 | netEarningsPerShare: | 3.6821 |
| currency: | USD |
| year: | 2023 | units: | 1000000 |
| balanceSheetTotal: | 62125.0000 | cash: | 6085.0000 |
| currentAssets: | 16085.0000 | fixedAssets: | 46040.0000 |
| liabilities: | 11280.0000 | totalLiabilitiesEquity: | 62125.0000 |
| totalShareholdersEquity: | 22749.0000 | property: | 5317.0000 |
| intangibleAssets: | 26454.0000 | longTermInvestments: | 1163.0000 |
| inventories: | 1787.0000 | accountsReceivable: | 4660.0000 |
| accountsPayable: | 550.0000 | liabilitiesTotal: | 39376.0000 |
| longTermDebt: | 23189.0000 | shortTermDebt: | 1798.0000 |
| minorityInterests: | -84.0000 | commonStock: | 1.0000 |
| preferredStock: | 0.0000 | sales: | 27116.0000 |
| netIncome: | 5665.0000 | operatingResult: | 7605.0000 |
| incomeInterest: | -944.0000 | investments: | 5718.0000 |
| incomeTaxes: | -1247.0000 | costGoodsSold: | 6498.0000 |
| grossProfit: | 20618.0000 | minorityInterestsProfit: | 52.0000 |
| cashFlow: | 8006.0000 | cashFlowInvesting: | -2265.0000 |
| cashFlowFinancing: | -5125.0000 | cashFlowTotal: | 673.0000 |
| accountingStandard: | US GAAP | equityRatio: | 36.6181 |
| debtEquityRatio: | 1.0984 | liquidityI: | 0.5395 |
| liquidityII: | 0.9526 | netMargin: | 20.8917 |
| grossMargin: | 76.0363 | cashFlowMargin: | 29.5250 |
| ebitMargin: | 28.0462 | ebitdaMargin: | 0.0000 |
| preTaxROE: | 30.1508 | preTaxROA: | 11.0406 |
| roe: | 24.9022 | roa: | 9.1187 |
| netIncomeGrowth: | 23.3667 | revenuesGrowth: | -0.6048 |
| taxExpenseRate: | -18.1805 | equityTurnover: | 1.1920 |
| epsBasic: | 4.5400 | epsDiluted: | 4.5000 |
| epsBasicGrowth: | 24.0437 | shareCapital: | 1.0000 |
| incomeBeforeTaxes: | 6859.0000 | priceEarningsRatioCompany: | 17.8436 |
| priceCashFlowRatio: | 12.6079 | dividendYield: | 3.7032 |
| bookValuePerShare: | 18.2576 | marketCap: | 100938460000.0000 |
| earningsYield: | 5.6042 | pegRatio: | 0.7421 |
| cashFlowPerShare: | 6.4254 | netAssetsPerShare: | 18.1902 |
| priceBookValueRatio: | 4.4371 | dividendsPerShare: | 3.0000 |
| priceEarningsRatio: | 17.8179 | netEarningsPerShare: | 4.5465 |
| currency: | USD |
| year: | 2024 | priceEarningsRatioCompany: | 18.6322 |
| priceCashFlowRatio: | 13.1650 | dividendYield: | 3.5465 |
| bookValuePerShare: | 18.2576 | marketCap: | 105399140000.0000 |
| earningsYield: | 5.3671 | pegRatio: | 0.7749 |
| cashFlowPerShare: | 6.4254 | netAssetsPerShare: | 18.2576 |
| priceBookValueRatio: | 4.6331 | priceEarningsRatio: | 18.6053 |
| netEarningsPerShare: | 4.5465 | currency: | USD |
Finanzen (ausführlich)
| year: | 2022 |
| units: | 1000000 |
| balanceSheetTotal: | 63171.0000 |
| cash: | 5412.0000 |
| currentAssets: | 14443.0000 |
| fixedAssets: | 48728.0000 |
| liabilities: | 11237.0000 |
| totalLiabilitiesEquity: | 63171.0000 |
| totalShareholdersEquity: | 21209.0000 |
| property: | 5475.0000 |
| intangibleAssets: | 28894.0000 |
| longTermInvestments: | 1245.0000 |
| inventories: | 1507.0000 |
| accountsReceivable: | 4777.0000 |
| accountsPayable: | 905.0000 |
| liabilitiesTotal: | 41962.0000 |
| longTermDebt: | 22957.0000 |
| shortTermDebt: | 2273.0000 |
| minorityInterests: | -31.0000 |
| commonStock: | 1.0000 |
| preferredStock: | 0.0000 |
| sales: | 27281.0000 |
| netIncome: | 4592.0000 |
| operatingResult: | 7330.0000 |
| incomeInterest: | -935.0000 |
| investments: | 4977.0000 |
| incomeTaxes: | -1248.0000 |
| costGoodsSold: | 5657.0000 |
| grossProfit: | 21624.0000 |
| minorityInterestsProfit: | 26.0000 |
| cashFlow: | 9072.0000 |
| cashFlowInvesting: | -2466.0000 |
| cashFlowFinancing: | -6469.0000 |
| cashFlowTotal: | 74.0000 |
| accountingStandard: | US GAAP |
| equityRatio: | 33.5740 |
| debtEquityRatio: | 1.1896 |
| liquidityI: | 0.4816 |
| liquidityII: | 0.9067 |
| netMargin: | 16.8322 |
| grossMargin: | 79.2640 |
| cashFlowMargin: | 33.2539 |
| ebitMargin: | 26.8685 |
| ebitdaMargin: | 0.0000 |
| preTaxROE: | 27.4129 |
| preTaxROA: | 9.2036 |
| roe: | 21.6512 |
| roa: | 7.2692 |
| netIncomeGrowth: | -26.2329 |
| revenuesGrowth: | -0.0879 |
| taxExpenseRate: | -21.4654 |
| equityTurnover: | 1.2863 |
| epsBasic: | 3.6600 |
| epsDiluted: | 3.6400 |
| epsBasicGrowth: | -26.2097 |
| shareCapital: | 1.0000 |
| incomeBeforeTaxes: | 5814.0000 |
| priceEarningsRatioCompany: | 23.4563 |
| priceCashFlowRatio: | 11.8016 |
| dividendYield: | 3.4013 |
| bookValuePerShare: | 17.0066 |
| marketCap: | 107063977470.9000 |
| earningsYield: | 4.2632 |
| pegRatio: | -0.8949 |
| cashFlowPerShare: | 7.2744 |
| netAssetsPerShare: | 16.9817 |
| priceBookValueRatio: | 5.0480 |
| dividendsPerShare: | 2.9200 |
| priceEarningsRatio: | 23.3153 |
| netEarningsPerShare: | 3.6821 |
| currency: | USD |
| year: | 2023 |
| units: | 1000000 |
| balanceSheetTotal: | 62125.0000 |
| cash: | 6085.0000 |
| currentAssets: | 16085.0000 |
| fixedAssets: | 46040.0000 |
| liabilities: | 11280.0000 |
| totalLiabilitiesEquity: | 62125.0000 |
| totalShareholdersEquity: | 22749.0000 |
| property: | 5317.0000 |
| intangibleAssets: | 26454.0000 |
| longTermInvestments: | 1163.0000 |
| inventories: | 1787.0000 |
| accountsReceivable: | 4660.0000 |
| accountsPayable: | 550.0000 |
| liabilitiesTotal: | 39376.0000 |
| longTermDebt: | 23189.0000 |
| shortTermDebt: | 1798.0000 |
| minorityInterests: | -84.0000 |
| commonStock: | 1.0000 |
| preferredStock: | 0.0000 |
| sales: | 27116.0000 |
| netIncome: | 5665.0000 |
| operatingResult: | 7605.0000 |
| incomeInterest: | -944.0000 |
| investments: | 5718.0000 |
| incomeTaxes: | -1247.0000 |
| costGoodsSold: | 6498.0000 |
| grossProfit: | 20618.0000 |
| minorityInterestsProfit: | 52.0000 |
| cashFlow: | 8006.0000 |
| cashFlowInvesting: | -2265.0000 |
| cashFlowFinancing: | -5125.0000 |
| cashFlowTotal: | 673.0000 |
| accountingStandard: | US GAAP |
| equityRatio: | 36.6181 |
| debtEquityRatio: | 1.0984 |
| liquidityI: | 0.5395 |
| liquidityII: | 0.9526 |
| netMargin: | 20.8917 |
| grossMargin: | 76.0363 |
| cashFlowMargin: | 29.5250 |
| ebitMargin: | 28.0462 |
| ebitdaMargin: | 0.0000 |
| preTaxROE: | 30.1508 |
| preTaxROA: | 11.0406 |
| roe: | 24.9022 |
| roa: | 9.1187 |
| netIncomeGrowth: | 23.3667 |
| revenuesGrowth: | -0.6048 |
| taxExpenseRate: | -18.1805 |
| equityTurnover: | 1.1920 |
| epsBasic: | 4.5400 |
| epsDiluted: | 4.5000 |
| epsBasicGrowth: | 24.0437 |
| shareCapital: | 1.0000 |
| incomeBeforeTaxes: | 6859.0000 |
| priceEarningsRatioCompany: | 17.8436 |
| priceCashFlowRatio: | 12.6079 |
| dividendYield: | 3.7032 |
| bookValuePerShare: | 18.2576 |
| marketCap: | 100938460000.0000 |
| earningsYield: | 5.6042 |
| pegRatio: | 0.7421 |
| cashFlowPerShare: | 6.4254 |
| netAssetsPerShare: | 18.1902 |
| priceBookValueRatio: | 4.4371 |
| dividendsPerShare: | 3.0000 |
| priceEarningsRatio: | 17.8179 |
| netEarningsPerShare: | 4.5465 |
| currency: | USD |
| year: | 2024 |
| priceEarningsRatioCompany: | 18.6322 |
| priceCashFlowRatio: | 13.1650 |
| dividendYield: | 3.5465 |
| bookValuePerShare: | 18.2576 |
| marketCap: | 105399140000.0000 |
| earningsYield: | 5.3671 |
| pegRatio: | 0.7749 |
| cashFlowPerShare: | 6.4254 |
| netAssetsPerShare: | 18.2576 |
| priceBookValueRatio: | 4.6331 |
| priceEarningsRatio: | 18.6053 |
| netEarningsPerShare: | 4.5465 |
| currency: | USD |
